PSC Support update
Progress and Plans at the ERN RARE-LIVER Members’ Meeting 2026
Martine Walmsley shares project updates and future goals from the 2026 Prague members’ meeting.
Read MoreLeadership Update
New PSC Support leadership announced
Read MoreMajor Milestone Reached in PSC Cancer Risk Study
100 samples collected: DNA methylation study advances early cancer detection in PSC.
Read MoreJanuary 2026 Research Roundup
PSC Support recently attended the British Association for the Study of the Liver (BASL) Immune Special Interest Group (SIG) meeting. This meeting highlighted important progress in research and care, and on new medications for autoimmune liver diseases.
Read MoreProgress Update: Characterising Genetic Changes in Bile Ducts
PSC research on genetic changes in bile ducts is now in its key analytical phase to unlock understanding.
Read MoreMolecular Signatures Identified to Predict Primary Sclerosing Cholangitis Progression and Cancer Risk
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.
Read MorePSC-IBD Bowel Cancer Risk Study Shows Promising Findings
New PSC-IBD research from Dr Chandni Radia suggests bowel cancer risk may be lower than previously thought, helping us build evidence to tailor future colonoscopy guidelines.
Read MorePromising Leap Forward in Research on PSC and Bile Duct Cancer
New research identifies a marker (COX2) linking lab models to real-world PSC patients, advancing early cancer detection efforts.
Read MoreMajor Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Major Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Read MoreResearch Update: New Clues to PSC Progression
Dr Anthony George shares new insights into immune cells and predicting PSC progression.
Read More